Skip to main content
. Author manuscript; available in PMC: 2016 Dec 2.
Published in final edited form as: Eur Respir J. 2016 Apr 21;47(6):1797–1808. doi: 10.1183/13993003.01469-2015

FIGURE 2.

FIGURE 2

Heatmap representing expressing profiles of beryllium-stimulated beryllium sensitisation (BeS), chronic beryllium disease (CBD) and control (Con) peripheral blood mononuclear cells determined by microarray analysis. Red indicates increased expression; green indicates decreased expression relative to the nonfailing population mean. Gradients indicate the level of gene expression change over time. Data range before thresholding: −2.7 to 2.9.